胶质瘤特征描述中的放射组学与深度预测建模综述
本文综述了基于多模态MRI生物标志物的计算机器学习或深度学习预测模型在胶质瘤基因分型、分子诊断、预后和治疗监测中的放射组学与人工智能应用,并讨论了扫描仪间变异、基准数据集需求及前瞻性验证等挑战。
要点
- 多模态MRI影像组学与深度学习模型可用于无创评估胶质瘤基因型。
- 影像基因组学将MRI表型与基因组改变关联,辅助分子诊断与预后。
- 扫描仪间变异与前瞻性验证是临床转化的主要挑战。
核心结论
- 基于多模态MRI生物标志物的机器学习或深度学习预测模型为胶质瘤基因型评估及个体化治疗提供了潜在保障。
- 影像组学与人工智能定量评估对胶质瘤分子诊断、预后和治疗监测具有重要价值。
研究设计与样本
- 综述整合了放射组学和人工智能学习方案在胶质瘤放射基因组分析中的最新工作。
- 纳入文献涉及基于多模态MRI的机器学习或深度学习预测模型,用于评估胶质瘤基因型。
诊断标准与关键数值
- 综述汇总了基于MRI手工提取或自动提取特征的放射组学与人工智能定量评估方法,用于胶质瘤分子诊断、预后和治疗监测。
临床应用与阅片要点
- 作者指出,基于MRI的影像组学与人工智能模型可能有助于胶质瘤分层和个体化治疗方案的制定。
局限性
- 扫描仪间变异是放射组学分析面临的挑战。
- 需要基准数据集以支持模型比较与验证。
- 临床适用性尚需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Recent developments in glioma categorization based on biological genotypes and application of computational machine learning or deep learning based predictive models using multi-modal MRI biomarkers to assess these genotypes provides potential assurance for optimal and personalized treatment plans and efficacy. Artificial intelligence based quantified assessment of glioma using MRI derived hand-crafted or auto-extracted features have become crucial as genomic alterations can be associated with MRI based phenotypes. This survey integrates all the recent work carried out in state-of-the-art radiomics, and Artificial Intelligence based learning solutions related to molecular diagnosis, prognosis, and treatment monitoring with the aim to create a structured resource on radiogenomic analysis of glioma. Challenges such as inter-scanner variability, requirement of benchmark datasets, prospective validations for clinical applicability are discussed with further scope for designing optimal solutions for glioma stratification with immediate recommendations for further diagnostic decisions and personalized treatment plans for glioma patients.
引用
- Gore S, Chougule T, Jagtap J, et al. A Review of Radiomics and Deep Predictive Modeling in Glioma Characterization. Acad Radiol. 2020. PMID: 32660755. doi:10.1016/j.acra.2020.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。